Chemotherapy

Clinical Publications

• Abiraterone Acetate and Prednisone in Patients (Pts) with Progressive Metastatic Castration Resistant Prostate Cancer (CRPC) After Failure of Docetaxel-Based Chemotherapy
  Wednesday, 13 August 2008
• Dasatinib in Patients with Hormone-Refractory Progressive Prostate Cancer: A Phase II Study
  Wednesday, 13 August 2008
• Docetaxel (D) Plus Prednisone (P) in Combination with Metronomic Cyclophosphamide (CTX) and Celecoxib (C) as First Line Chemotherapy in Metastatic Hormone Refractory Prostate Cancer (HRPC): Phase II Clinical Trial with Pharmacodynamic Evaluation
  Wednesday, 13 August 2008
• Masters in Urology 2008 - Advances in the Treatment of Hormone Refractory Prostate Cancer
  Monday, 11 August 2008
• Current Status of Cytotoxic Chemotherapy in Patients with Metastatic Prostate Cancer
  Wednesday, 09 July 2008
• Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy
  Friday, 04 July 2008
• Antitumour Effect of Electrochemotherapy with Bleomycin on Human Prostate Cancer Xenograft
  Friday, 20 June 2008
• Beyond the Abstract - The Combination of Docetaxel and the Somatostatin Analogue Lanreotide on Androgen-Independent Docetaxel-Resistant Prostate Cancer: Experimental Data
  Tuesday, 10 June 2008
• Chemotherapy in Hormone-Refractory Prostate Cancer
  Wednesday, 09 April 2008
• Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
  Monday, 07 April 2008
• EAU 2008 - Chemotherapy and New Concepts in Hormone-Refractory Prostate Cancer
  Friday, 04 April 2008
• Pilot Trial of Adjuvant Paclitaxel Plus Estramustine in Resected High-Risk Prostate Cancer
  Wednesday, 05 March 2008
• Combination of Bevacizumab and Docetaxel in Docetaxel-Pretreated Hormone-Refractory Prostate Cancer: A Phase 2 Study
  Monday, 03 March 2008
• Neoadjuvant Docetaxel and Capecitabine in Patients With High Risk Prostate Cancer
  Friday, 29 February 2008
• ASCO GU 2008 - Impact of the Specific Endothelin A Receptor Antagonist ZD4054 on Overall Survival and Bone Metastasis in Patients with Hormone-Resistant Prostate Cancer: Results of a Phase II Trial
  Saturday, 16 February 2008
• ASCO GU 2008 - Management of Post-Docetaxel Treatment
  Saturday, 16 February 2008
• Equivalent and Sufficient Effects of Leuprolide Acetate and Goserelin Acetate to Suppress Serum Testosterone Levels in Patients With Prostate Cancer
  Wednesday, 13 February 2008
• WUF 2008 - Serum PSA in Guiding Therapy for Men on Androgen Deprivation Therapy and for Men with Hormone Refractory Prostate Cancer
  dSaturday, 02 February 2008
• Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
  Thursday, 17 January 2008
• Beyond the Abstract - Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Apoplexy in Treatment of Prostate Cancer: Case Report and Review of Literature
  Wednesday, 05 December 2007
• SUO 2007 - Prostate Cancer III: “New Options for Hormone Refractory Disease”
  Monday, 03 December 2007
• Survival in Men with Nonmetastatic Prostate Cancer Treated with Hormone Therapy: A Quantitative Systematic Review
  Friday, 30 November 2007
• Chemotherapy for the Treatment of Hormone-Refractory Prostate Cancer
  Wednesday, 21 November 2007
• Weekly Administration of Docetaxel in Combination with Estramustine and Celecoxib in Patients with Advanced Hormone-Refractory Prostate Cancer: Final Results from a Phase II Study
  Tuesday, 20 November 2007
• The Radiation Response of Hormone-Resistant Prostate Cancer Induced by Long-Term Hormone Therapy
  Thursday, 01 November 2007
• SIU 2007 POD [04.06] - Hedgehog Signaling in Advanced Prostate Cancer
  Monday, 03 September 2007
• SIU 2007 POD [04.02] - The Percentage of Positive Biopsies Is an Independent Predictor of Survival at the Onset of Hormonal Treatment for Advanced Prostate Cancer
  Monday, 03 September 2007
• Luteinising Hormone-Releasing Hormone Antagonists in Prostate Cancer Therapy - Abstract
  Monday, 03 September 2007
• Docetaxel and Cisplatin in Patients with Metastatic Androgen Independent Prostate Cancer and Circulating Neuroendocrine Markers
  Wednesday, 29 August 2007
• Impact of PSA Flare-up in Patients with Hormone-Refractory Prostate Cancer Undergoing Chemotherapy - Abstract
  Wednesday, 22 August 2007
• Docetaxel, Low-Dose Estramustine, and Doxifluridine in Hormone-Refractory Metastatic Prostate Cancer - Abstract
  August 21, 2007
• New Paradigms for Advanced Prostate Cancer - Abstract
  August 20, 2007
• Neoadjuvant Docetaxel Treatment for Locally Advanced Prostate Cancer: a Clinicopathologic Study
  Tuesday, 07 August 2007
• Adjuvant Weekly Docetaxel for Patients with High Risk Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Pilot Study
  Friday, 11 May 2007
• Advanced Prostate Cancer - Comparative Reviews of the Major Guidelines
  Thursday, 12 April 2007
• Weekly Docetaxel and Prednisolone versus Prednisolone Alone in Androgen-Independent Prostate Cancer: A Randomized Phase II Study
  Friday, 02 March 2007
• European Urology - Current Indications for Chemotherapy in Prostate Cancer Patients
  Monday, 01 January 2007
• European Urology - Looking Back at PCPT: Looking Forward to New Paradigms in Prostate Cancer Screening and Prevention
  Monday, 01 January 2007
• Survey Reveals Physician Misconceptions of Combined Hormonal Therapy for Advanced Prostate Cancer
  Wednesday, 01 November 2006
• Dendreon Announces New Data Analysis Presented at Chemotherapy Foundation Symposium
  Friday, 10 November 2006
• Debate: What is the Optimum Timing of Systemic Therapy in Conjunction with Radical Prostatectomy for Locally Advanced Disease?
  Saturday, 02 December 2006
• European Urology - Update on Phosphodiesterase (PDE) Isoenzymes as Pharmacologic Targets in Urology: Present and Future
  Thursday, 23 November 2006
• European Urology - Management of the Spectrum of Hormone Refractory Prostate Cancer
  Wednesday, 20 September 2006
• URS 2006 - Effects of a New Oncolytic Adenovirus (Xvir03) in Human Prostate Cancer Cell Lines and in a Xenograft Mouse Model
  Sunday, 10 September 2006
• Few Well Performed Studies Address Management Of Lymph Node Positive Prostate Cancer
  Monday, 26 June 2006
• ASCO 2006 - GU Oral Presentation: Prostate Cancer
  Wednesday, 07 June 2006
• ASCO 2006 - GU Prostate Cancer Abstracts
  Tuesday, 06 June 2006
• Phase I Study Combining Gefitinib With Docetaxel And Estramustine Reported
  Thursday, 15 June 2006
• AUA 2006 - Prostate Cancer Targeted Therapy With Antisense Oligonucleotides
  Sunday, 21 May 2006
• AUA 2006 - Prostate Cancer Localized III Session
  Wednesday, 24 May 2006
• AUA 2006 - High-Risk Prostate Cancer Presented by Dr. Benson
  Wednesday, 24 May 2006
• EAU 2006 - ABST [289] Second-line chemotherapy with docetaxel for prostate-specific antigen (PSA) relapse in men with hormone-refractory prostate cancer (HRPC) previously treated with docetaxel-based chemotherapy
  Monday, 10 April 2006
• EAU 2006 - ABST [288] A phase II clinical study of high-dose Calcitriol plus Docetaxel and Zoledronic acid in hormone-refractory prostate cancer (HRPC)
  Monday, 10 April 2006
• Progen Expand PI-88 Clinical Development To Prostate Cancer
  Tuesday, 09 August 2005
• Cell Genesys Initiates Second Phase 3 Clinical Trial Of GVAX® Vaccine For Prostate Cancer
  Tuesday, 05 July 2005
• Using PET Scan Technology to Measure Treatment Response In Metastatic Prostate Cancer
  Monday, 13 June 2005
• EAU 2005 - ABST[568] Phase 2 Protocol with Docetaxel Plus Prednisone in Patients with Hormone Refractory Prostate Cancer
  Thursday, 09 June 2005
• EAU 2005 - ABST[981] PSA-Flare up in Docetaxel Therapy of HRPC: Incidence and Clinical Impact?
  Thursday, 09 June 2005
• EAU 2005 - ABST[993] Weekly Docetaxel, Zoledronic Acid, and Estramustine in Metastatic Androgen-Independent Prostate Cancer (MAIP)
  Thursday, 09 June 2005
• EAU 2005 - ABST[570] Docetaxel, Estramustine and Prednisone for the Treatment of Hormone Refractory Prostate Cancer: A Single Center Experience
  Thursday, 09 June 2005
• Genitinib and Docetaxel in Combination Therapy for Bladder Cancer, May 23, 2005
  Monday, 23 May 2005
• Docetaxel-Containing Regimens Improve Survival in Advanced Prostate Cancer
  Thursday, 07 October 2004
• Docetaxel Improves Survival in Hormone-Refractory Prostate Cancer
  Thursday, 10 June 2004
• Taxotere Can Increase Survival in Prostate Cancer Patients
  Tuesday, 08 June 2004
• Plenary Session: Docetaxel-based Chemotherapy in Hormone Refractory Prostate Cancer
  Monday, 07 June 2004
• Plenary Session: Docetaxel-based Chemotherapy in Hormone Refractory Prostate Cancer
  Monday, 07 June 2004
• New Cancer Strides to Be Unveiled at Big Meeting
  Thursday, 03 June 2004
• Two Landmark Studies of Taxotere� in Prostate Cancer Highlighted in American Society of Clinical Oncology Plenary Session
  Monday, 31 May 2004
• Aberalix Helpful in Some Advanced Prostate Cancer Patients
  Tuesday, 11 May 2004
• Society of Urologic Oncology Annual Meeting
  Saturday, 08 May 2004

Please log-in or register in order to submit comments.

Powered by AkoComment!